Cargando…
Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496938/ https://www.ncbi.nlm.nih.gov/pubmed/34654666 http://dx.doi.org/10.1016/j.jmii.2021.07.016 |
| _version_ | 1784579856382558208 |
|---|---|
| author | Lo, Ching-Lung Syue, Ling-Shan Ko, Wen-Chien |
| author_facet | Lo, Ching-Lung Syue, Ling-Shan Ko, Wen-Chien |
| author_sort | Lo, Ching-Lung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8496938 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84969382021-10-08 Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome? Lo, Ching-Lung Syue, Ling-Shan Ko, Wen-Chien J Microbiol Immunol Infect Correspondence Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2022-02 2021-10-07 /pmc/articles/PMC8496938/ /pubmed/34654666 http://dx.doi.org/10.1016/j.jmii.2021.07.016 Text en © 2021 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Lo, Ching-Lung Syue, Ling-Shan Ko, Wen-Chien Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome? |
| title | Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome? |
| title_full | Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome? |
| title_fullStr | Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome? |
| title_full_unstemmed | Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome? |
| title_short | Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome? |
| title_sort | oral dexamethasone for covid-19 patients at the initial recognition of hypoxia: can an early dose herald a better outcome? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496938/ https://www.ncbi.nlm.nih.gov/pubmed/34654666 http://dx.doi.org/10.1016/j.jmii.2021.07.016 |
| work_keys_str_mv | AT lochinglung oraldexamethasoneforcovid19patientsattheinitialrecognitionofhypoxiacananearlydoseheraldabetteroutcome AT syuelingshan oraldexamethasoneforcovid19patientsattheinitialrecognitionofhypoxiacananearlydoseheraldabetteroutcome AT kowenchien oraldexamethasoneforcovid19patientsattheinitialrecognitionofhypoxiacananearlydoseheraldabetteroutcome |